Physician profile
Gregory Miller
NPI 1770688764
$1,354.81
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.33 · 2020: $39.33 · 2021: $154 · 2023: $563 · 2024: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $164.91 | 2023-2024 | Vitalpatch Rtm |
| Abiomed | $143.06 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $137.76 | 2019-2024 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $106.72 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $93.10 | 2024 | Arcalyst |
| Pfizer INC. | $88.70 | 2019-2024 | |
| Amgen INC. | $80.69 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $72.24 | 2023-2024 | Wainua, Andexxa, Farxiga |
| Novartis Pharmaceuticals Corporation | $70.01 | 2023-2024 | |
| Abbott Laboratories | $60.92 | 2020-2023 | Jot Dx, Xience Skypoint |
| Boston Scientific Corporation | $60.82 | 2023-2024 | Watchman Access System, Bodyguardian |
| Edwards Lifesciences Corporation | $50.54 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $46.88 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $43.91 | 2023-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.31 | 2023-2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $21.63 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $20.74 | 2023 | Onpattro |
| Kiniksa Pharmaceuticals, Ltd. | $19.27 | 2023 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $16.90 | 2024 | Livalo |
| Biotronik INC. | $14.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.